Vulpinic acid
Product Specifications
UNSPSC Description
Vulpinic acid, a lichen metabolite, decreases H2O2-induced ROS production, oxidative stress and oxidative stress-related damages in human umbilical vein endothelial cells (HUVEC). Vulpinic acid is active against staphylococci, enterococci, and anaerobic bacteria.Vulpinic acid has the potential for atherosclerosis research[1][2].
Target Antigen
Bacterial; Endogenous Metabolite; Reactive Oxygen Species
Type
Natural Products
Related Pathways
Anti-infection;Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κB
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vulpinic-acid.html
Purity
99.62
Solubility
DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
COC(/C(C1=CC=CC=C1)=C2C(O)=C(C3=CC=CC=C3)C(O\2)=O)=O
Molecular Weight
322.31
References & Citations
[1]E Sahin, et al. Vulpinic acid, a lichen metabolite, emerges as a potential drug candidate in the therapy of oxidative stress-related diseases, such as atherosclerosis. Hum Exp Toxicol. 2019 Jun;38(6):675-684.|[2]M Lauterwein, et al. In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms. Antimicrob Agents Chemother. 1995 Nov;39(11):2541-3.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-125919/Vulpinic-acid-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-125919/Vulpinic-acid-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
521-52-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
